Next-generation Sequencing Services Market is segmented by Type (Targeted Sequencing, Exome, RNA-Seq, ChIP Sequencing), Technology (Sequencing by Synthesis, Nanopore, SMRT), Application (Clinical Diagnosis, Biomarker Discovery), End User and Geography.

The Next-Generation Sequencing Services Market is expected to grow at a CAGR of 20.4% from 2021 to 2028 reaching USD 14.1 billion by 2028.

Next-generation sequencing (NGS) is a DNA sequencing technology that has developed genomic research massively. As compared to Sanger sequencing technology where it is used to decipher the human genome, NGS has surpassed Sanger sequencing but still has not yet turned into routinary clinical practice.

NGS’ Potential Uses and Market Growth

Countless opportunities are opened for NGS most especially in the medical field. It has a wider range of scope with respect to mutations compared to Sanger sequencing. The growth and development of this market is mainly attributed to the lesser cost of NGS procedures, number of new targeted therapies being approved, rise in the cases of cancer, partnerships made by NGS service providers and pharmaceutical companies, costly sequencing infrastructure, and advanced technologies in NGS. The improvements in sequencing data analytics and the rise of NGS applications in cancer as well as agri-genomics research have made a significant impact on the growth of NGS Sequencing Market.

COVID-19 Impact on the Market

The rise of COVID-19 cases can be one of the negative factors that can hinder the growth of NGS services market since hospitals and medical clinics have a surge when it comes to the volume of COVID-19 cases. Hospitals and clinics prioritized COVID-19 cases and is limited when it comes to physical interaction because controlling the spread of virus is of top priority. Another restraint is the disrupt in the supply chain with respect to manufacturing and distribution of NGS equipment. The strict protocols and lock downs imposed by the governments globally, caused the decline of scheduled experiments and facility operations because most of it have already been postponed.

Positively, NGS services has contributed on slowly unraveling SARS-CoV-2 genome sequence. It is an important milestone since the NGS has helped researchers to have additional information on the virus and how it develops. The monitoring and assessing of the virus’ transmission, activity, as well as its evolution was made easier because of the continued genome sequencing.

Key Findings in the Global Next-Generation Sequencing Services Market Study

In terms of type, it is segmented into targeted sequencing services, whole-genome sequencing services, RNA sequencing services, exome sequencing services, de novo sequencing services, ChIP sequencing services, methyl sequencing services, and other NGS services. Out of all the segment, the exome sequencing services is projected to grow at the highest CAGR in 2021-2028. The growth is mainly attributed to its cost-effectiveness to the whole genome sequencing.

In terms of technology, it is segmented further into sequencing by synthesis (SBS), ion semiconductor sequencing (IOS), single-molecule real-time sequencing (SMRT), nanopore sequencing, and other NGS technologies. During the forecast period, the single-molecule real-time sequencing (SMRT) is projected to grow at the highest CAGR. The growth is attributed to the ability of its technology in providing highly accurate long reads.

In terms of application, it is segmented into biomarker discovery, diagnostics, drug discovery, agriculture & animal research, and other applications. During the forecast period, the biomarker discovery segment is projected to have the highest CAGR. Presence of NGS in discovering biomarkers provides a breakthrough in predicting and monitoring diseases like cancer and chronic diseases. Biomarkers are significant in early diagnosis, determining therapeutic efficacy of medicines, predictions.

In terms of end user, the market is segmented into hospitals & clinics, pharmaceutical and biotechnology companies, academic and research institutes, and other end users. Hospitals and clinics is anticipated to have the largest share accounted for in 2021.

Regional Market Analysis

In terms of region, the NGS services market is further segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America however, is expected to account for the largest share in the market in 2021 due to government favored initiatives, presence of leading NGS providers in the regions, numerous applications of NGS-based research, investments by major key players, and favorable reimbursement.

Share and Competition in Key Market Players

The key players in the NGS services market who are leading in providing NGS services are, Illumina, Inc. (U.S.), Qiagen N.V. (Netherland), PerkinElmer, Inc. (U.S.), Eurofins Scientific S.E. (Luxembourg), Macrogen, Inc. (South Korea), LGC Limited (U.K.), GENEWIZ, Inc. (U.S.), Beijing Genomics Institute (BGI) (China), SciGenom Labs Pvt. Ltd (India), MedGenome Inc. (U.S.), DNA Link, Inc. (South Korea), Otogenetics Corporation (U.S.), Novogene Co., Ltd. (China), CD Genomics (U.S.), Foundation Medicine, Inc. (U.S), and SeqLL, Inc. (U.S.).

Report Highlights
• Historical data available (as per request)
• Estimation/projections/forecast for revenue and unit sales (2022 – 2032)
• Data breakdown for every market segment (2022 – 2032)
• Gross margin and profitability analysis of companies
• Price analysis of each product type
• Business trend and expansion analysis
• Import and export analysis
• Competition analysis/market share
• Supply chain analysis
• Client list and case studies
• Market entry strategy

Industry Segmentation and Revenue Breakdown

Type Analysis (Revenue, USD Million, 2022 - 2032)

• Targeted Sequencing Services
• RNA Sequencing Services
• De Novo Sequencing Services
• Exome Sequencing Services
• Chip Sequencing Services
• Whole-genome Sequencing Services
• Methyl Sequencing Services
• Other Services

Technology Analysis (Revenue, USD Million, 2022 - 2032)

• Sequencing By Synthesis (SBS)
• Ion Semiconductor Sequencing (IOS)
• Single-molecule Real-time Sequencing (SMRT)
• Nanopore Sequencing
• Other Technologies

Application Analysis (Revenue, USD Million, 2022 - 2032)

• Diagnostics
• Drug Discovery
• Biomarker Discovery
• Agriculture & Animal Research
• Other Applications

End User Analysis (Revenue, USD Million, 2021 - 2028)

• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Academics & Research Institutes
• Other End Users

Region Analysis (Revenue, USD Million, 2022 – 2032)

• United States
• Canada
• Mexico
• France
• Germany
• Italy
• Spain
• United Kingdom
• Russia
• China
• India
• Philippines
• Malaysia
• Australia
• Austria
• South Korea
• UAE
• Qatar
• Saudi Arabia
• Japan
• Africa
• Rest of World

Available Versions:
• United States Next Generation Sequencing Services Industry Research Report
• Europe Next Generation Sequencing Services Industry Research Report
• Asia Pacific Next Generation Sequencing Services Industry Research Report

Need report on this market for specific region or Country? Or need a customized report as per your need? Want to know discounts as available?

Email US

David Correa

david@marketdecipher.com

Or Fill the form below "Sample Request Form" with your queries in message box.